Lantheus Holdings Inc (LNTH)
67.45
+0.92
(+1.38%)
USD |
NASDAQ |
May 01, 16:00
69.25
+1.80
(+2.67%)
After-Hours: 18:06
Lantheus Holdings Revenue (Quarterly): 354.00M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 354.00M |
| September 30, 2023 | 319.95M |
| June 30, 2023 | 321.70M |
| March 31, 2023 | 300.78M |
| December 31, 2022 | 263.17M |
| September 30, 2022 | 239.29M |
| June 30, 2022 | 223.72M |
| March 31, 2022 | 208.88M |
| December 31, 2021 | 129.56M |
| September 30, 2021 | 102.07M |
| June 30, 2021 | 101.06M |
| March 31, 2021 | 92.51M |
| December 31, 2020 | 94.15M |
| September 30, 2020 | 88.54M |
| June 30, 2020 | 66.01M |
| March 31, 2020 | 90.70M |
| December 31, 2019 | 89.35M |
| September 30, 2019 | 85.78M |
| June 30, 2019 | 85.70M |
| March 31, 2019 | 86.51M |
| December 31, 2018 | 86.27M |
| September 30, 2018 | 88.90M |
| Date | Value |
|---|---|
| June 30, 2018 | 85.57M |
| March 31, 2018 | 82.63M |
| December 31, 2017 | 81.24M |
| September 30, 2017 | 79.94M |
| June 30, 2017 | 88.84M |
| March 31, 2017 | 81.36M |
| December 31, 2016 | 74.35M |
| September 30, 2016 | 73.06M |
| June 30, 2016 | 77.97M |
| March 31, 2016 | 76.47M |
| December 31, 2015 | 71.20M |
| September 30, 2015 | 74.12M |
| June 30, 2015 | 73.31M |
| March 31, 2015 | 74.82M |
| December 31, 2014 | 76.97M |
| September 30, 2014 | 75.68M |
| June 30, 2014 | 75.61M |
| March 31, 2014 | 73.34M |
| December 31, 2013 | 71.67M |
| September 30, 2013 | 70.38M |
| June 30, 2013 | 70.60M |
| March 31, 2013 | 71.02M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
66.01M
Minimum
Jun 2020
354.00M
Maximum
Dec 2023
171.42M
Average
102.07M
Median
Sep 2021
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -5.239M |
| Boston Scientific Corp | 3.856B |
| Edwards Lifesciences Corp | 1.598B |
| NeuroMetrix Inc | 1.318M |
| Stryker Corp | 5.815B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 103.38M |
| Total Expenses (Quarterly) | 216.51M |
| EPS Diluted (Quarterly) | 1.47 |
| Enterprise Value | 4.408B |
| Gross Profit Margin (Quarterly) | 64.93% |
| Profit Margin (Quarterly) | 29.20% |
| Earnings Yield | 6.88% |
| Operating Earnings Yield | 7.75% |
| Normalized Earnings Yield | 6.060 |